CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Hematologic Malignancies » Leukemia and Lymphoma


SearchMedica News From a top search during the past week on SearchMedica
 

What's Driving The Increase in Pediatric Hodgkin Lymphoma?

December 13, 2012

The incidence of pediatric Hodgkin lymphoma (HL) has been on the upswing in many countries over the last few decades. Researchers in Sweden took a closer look at any possible perinatal risk factors for the disease in a cohort of more than 3 million people. The two intriguing key elements strongly associated with a higher risk for HL from ages 0 to 37, fetal growth rate and family history, suggest tantalizing links to growth factor pathways.

RESULT: Perinatal and Family Risk Factors for Hodgkin Lymphoma in Childhood Through Young Adulthood
American Journal of Epidemiology | Nov 21, 2012 (Free abstract. Full text $40)


From genetic sequencing in Burkitt lymphoma (abstract 12) to the expanding role of immunotherapy in HL (abstract 127), the presentations from the 2012 International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin's Lymphoma, held last month, offer the latest in cutting-edge research in this subspecialty. This year's abstracts also have real-world clinical news in the form of case studies, including one on a rectal polyp that turned out to be a rare case of pediatric follicular lymphoma (abstract 147).

RESULT: Abstracts of the Fourth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin's Lymphoma
British Journal of Haematology (PubMed) | Nov 01, 2012 (FREE FULL TEXT)

 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

Radiotherapy Is NOT Essential to Cure Diffuse Large B-Cell Non-Hodgkin Lymphoma
ONCOLOGY,  May 15, 2013
Making Good Results Even Better: The Evolving Role of Radiotherapy in Patients With Early Diffuse Large B-Cell Lymphoma
ONCOLOGY,  May 15, 2013
Nilotinib Associated With Increased Peripheral Artery Disease Rate in CML
May 13, 2013
AML Genome Reveals Complexities, Potential Driver Mutations
May 4, 2013
Are CML Drugs Priced Out of Reach?
May 2, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 

 
IMAGE IQ

46-Year-Old CML Patient Develops Painful Ulceration
Ted Rosen, MD , September 10, 2012

A hematologically stable CML patient developed a solitary, exquisitely painful ulceration, 7 cm × 5 cm, located on the mid-medial foreleg. There was never any evidence of venous insufficiency. The patient denied the possibility of a spider bite. What is the likely cause of this lesion?


 
Most Popular
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
Comments
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Leukemia
Evidence on Leukemia
Guidelines on Leukemia
Patient Education on Leukemia
Clinical Trials on Leukemia
Practical Articles on Leukemia
Research and Reviews on Leukemia
All "Leukemia" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy